EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Expression and clinical significance of HER2/neu, aromatase P450 and adhesion molecule CD24 in endometrial cancer

Liyun Guan, Ying Wang, Jianxin Cheng, Jun Zhang, Shan Kang

European Journal of Histochemistry · 2023

DOI: 10.4081/ejh.2023.3655 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Histochemistry, 2023. Verfasst von Liyun Guan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The Third Hospital of Shijiazhuang. 394677291@qq.com. Hauptthemen laut MEDLINE: Endometrial Hyperplasia, Endometrial Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed at exploring the expression and clinical significance of aromatase P450, adhesion molecule CD24 and HER2/neu in endometrial cancer. The expression of aromatase P450, adhesion molecule CD24 and HER2/neu was detected by immunohistochemistry in 15 cases of endometrial hyperplasia group, 50 cases of endometrial adenocarcinoma and 3 cases of uterine papillary adenocarcinoma, with 15 cases of normal endometrium as control group. We detected no expression of aromatase P450, adhesion molecule CD24 or HER2/neu in control group. Aromatase P450 positive expression rate was 66.7% in endometrial hyperplasia group and 70.3% in endometrial carcinoma group, without significant difference (p>0.05). There was no significant difference (p>0.05) in the positive expression rate of aromatase P450 between different myometrial invasion groups of endometrial adenocarcinomas. CD24 positive expression rate was 40.0% in endometrial hyperplasia group and 79.6% in endometrial carcinoma group, with significant difference (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endometrial HyperplasiaEndometrial NeoplasmsFemaleHumansAromataseClinical RelevanceImmunohistochemistryEndometriumCD24 Antigen

Substanzen

AromataseCD24 protein, humanCD24 Antigen

Autor:innen und Institutionen

  • Department of Oncology, The Third Hospital of Shijiazhuang. 394677291@qq.com.
  • Department of Obstetrics and Gynecology, The Fourth Hospital of Hebei Medical University, Shijiazhuang. 15833925141@139.com.
  • Department of Obstetrics and Gynecology, The Fourth Hospital of Hebei Medical University, Shijiazhuang. jianxin_cheng@263.net.
  • Department of Obstetrics and Gynecology, The Fourth Hospital of Hebei Medical University, Shijiazhuang. 3176623197@qq.com.
  • Department of Obstetrics and Gynecology, The Fourth Hospital of Hebei Medical University, Shijiazhuang. ksjq62cn@sina.com.

Zitieren

APA

Guan, L., Wang, Y., Cheng, J., Zhang, J., & Kang, S. (2023). Expression and clinical significance of HER2/neu, aromatase P450 and adhesion molecule CD24 in endometrial cancer. European Journal of Histochemistry. https://doi.org/10.4081/ejh.2023.3655

Vancouver

Guan L, Wang Y, Cheng J, Zhang J, Kang S. Expression and clinical significance of HER2/neu, aromatase P450 and adhesion molecule CD24 in endometrial cancer. European Journal of Histochemistry. 2023. doi:10.4081/ejh.2023.3655

BibTeX
@article{Guan2023,
  author = {Guan, Liyun and Wang, Ying and Cheng, Jianxin and Zhang, Jun and Kang, Shan},
  title = {Expression and clinical significance of HER2/neu, aromatase P450 and adhesion molecule CD24 in endometrial cancer},
  journal = {European Journal of Histochemistry},
  year = {2023},
  doi = {10.4081/ejh.2023.3655}
}
Kostenlos starten →